This session is focused on mechanistic, translational and clinical aspects of drug-induced liver injury (DILI). Speakers will share an update on the traditional chemotherapy DILI and discuss liver-related side effects of novel cancer chemotherapeutics, su

Part 1: Weight Management in cirrhosis and PRE-Transplant candidates: Medical vs Endobariatric vs surgical management

Part 2: Health Disparities in Underrepresented & Unique Populations

Part 2: Cross talk with the immune system and gut-brain axis

Breakout B: Liver Cancer

This session will provide the tools needed for correct identification and prognostication of patients undergoing early liver transplantation for severe alcohol-associated liver disease. Additionally, attendees will gain an understanding of the keys of psy

Part 3: Endoscopic management for cancer screening in Cirrhotics and Pre-transplant -candidates

Part 4: Endoscopic management of complex diseases in Cirrhotics and Pre-transplant candidates

The goal of this program is equip clinical and translational researchers with the tools and framework to apply towards advancing biomarker research in alcohol-associated liver disease (ALD). This program will provide an overview of biomarker categories an

The session will review specific clinical practice challenges hepatology specialist may encounter, including optimizing cirrhotic patients for surgery, estimating MASLD fibrosis severity using non-invasive measures, determining the best time span to utili